This approach of seeking FDA approval for specific, well-defined conditions sets Neurovalens apart from some other players in the neurotech space. By focusing on precise patient segments and tailoring their devices to treat specific disorders, they aim to maximize efficacy and minimize the variability in patient outcomes that can be a challenge for neurotech treatments.